Clinical trials
Phase 3 Neoplasms by Site trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Sumitomo Pharma America, Inc. | 2 |
| Abbott | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Celgene | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Imunon | 1 |
| Karyopharm Therapeutics Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 16 |
| Neoplasms | 15 |
| Digestive System Diseases | 6 |
| Digestive System Neoplasms | 6 |
| Adenocarcinoma | 5 |
| Carcinoma | 5 |
| Neoplasm Metastasis | 5 |
| Neoplasms by Histologic Type | 5 |
| Breast Diseases | 4 |
| Breast Neoplasms | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.